Literature DB >> 11986992

Delayed pharmacological effects of antidepressants.

A Frazer1, S Benmansour.   

Abstract

Although antidepressants may not be primary mood stabilizers, they are efficacious in the prophylaxis of recurrent depressive illnesses, as well as in the treatment of acute episodes. Pharmacological effects that may contribute to the prophylactic effects of these drugs are not understood. Studies have been carried out in which antidepressants have been given to laboratory animals, such as rats, for periods of up to 3-4 weeks. Data obtained in such studies are thought to be important for their beneficial effects in depressive episodes, but also may be relevant to their prophylactic effects. Results are presented showing that when selective inhibitors of serotonin or norepinephrine uptake are given for such time periods, they still produce selective effects on serotonergic or noradrenergic parameters. For example, long-term administration of selective norepinephrine reuptake inhibitors causes a down-regulation of beta(1) adrenoceptors. Selective serotonin reuptake inhibitors do not produce this effect. Long-term administration of selective serotonin reuptake inhibitors causes down-regulation of the serotonin transporter, but not the norepinephrine transporter. In contrast, selective norepinephrine reuptake inhibitors down-regulate the norepinephrine transporter but not the serotonin transporter. Substantial loss of serotonin transporter binding sites takes 15 days to occur and is accompanied by a marked reduction of serotonin transporter function in vivo.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11986992     DOI: 10.1038/sj.mp.4001015

Source DB:  PubMed          Journal:  Mol Psychiatry        ISSN: 1359-4184            Impact factor:   15.992


  47 in total

1.  The Unpredictable Chronic Mild Stress Protocol for Inducing Anhedonia in Mice.

Authors:  Or Burstein; Ravid Doron
Journal:  J Vis Exp       Date:  2018-10-24       Impact factor: 1.355

Review 2.  Fish oil and depression: The skinny on fats.

Authors:  Mansoor D Burhani; Mark M Rasenick
Journal:  J Integr Neurosci       Date:  2017       Impact factor: 2.117

3.  Estrogen receptor β deficiency impairs BDNF-5-HT2A signaling in the hippocampus of female brain: A possible mechanism for menopausal depression.

Authors:  Anindit Chhibber; Sarah K Woody; M A Karim Rumi; Michael J Soares; Liqin Zhao
Journal:  Psychoneuroendocrinology       Date:  2017-05-18       Impact factor: 4.905

4.  Association of changes in norepinephrine and serotonin transporter expression with the long-term behavioral effects of antidepressant drugs.

Authors:  Zaorui Zhao; Han-Ting Zhang; Elianna Bootzin; Mark J Millan; James M O'Donnell
Journal:  Neuropsychopharmacology       Date:  2008-10-15       Impact factor: 7.853

5.  Time course of the effects of the serotonin-selective reuptake inhibitor sertraline on central and peripheral serotonin neurochemistry in the rhesus monkey.

Authors:  George M Anderson; Christina S Barr; Stephen Lindell; Amy C Durham; Ilya Shifrovich; J Dee Higley
Journal:  Psychopharmacology (Berl)       Date:  2004-09-25       Impact factor: 4.530

Review 6.  Antidepressants and Cdk inhibitors: releasing the brake on neurogenesis?

Authors:  Vera Chesnokova; Robert N Pechnick
Journal:  Cell Cycle       Date:  2008-06-17       Impact factor: 4.534

Review 7.  3,4-Methylenedioxymethamphetamine (MDMA) neurotoxicity in rats: a reappraisal of past and present findings.

Authors:  Michael H Baumann; Xiaoying Wang; Richard B Rothman
Journal:  Psychopharmacology (Berl)       Date:  2006-03-16       Impact factor: 4.530

8.  Neural and cardiac toxicities associated with 3,4-methylenedioxymethamphetamine (MDMA).

Authors:  Michael H Baumann; Richard B Rothman
Journal:  Int Rev Neurobiol       Date:  2009       Impact factor: 3.230

9.  Norepinephrine transporter regulation mediates the long-term behavioral effects of the antidepressant desipramine.

Authors:  Zaorui Zhao; Alicia M Baros; Han-Ting Zhang; M Danet S Lapiz; Corina O Bondi; David A Morilak; James M O'Donnell
Journal:  Neuropsychopharmacology       Date:  2008-04-16       Impact factor: 7.853

Review 10.  A neurocognitive model for understanding treatment action in depression.

Authors:  Matthew B Warren; Abbie Pringle; Catherine J Harmer
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2015-09-19       Impact factor: 6.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.